Houston, TX

Dr. Roy Sillitoe receives the NINDS Landis Award for Outstanding Mentorship

Marisol Gallagher

Online Marketing/Unsplash

HOUSTON, TX — Dr. Roy Sillitoe, an associate professor of neuroscience and pathology and immunology at Baylor College of Medicine and investigator at the Jan and Duncan Neurological Research Institute at Texas Children’s Hospital, has been selected as one of the 2021 award recipients for the NINDS Landis Award for Outstanding Mentorship.

Back in 2018, the National Institute of Neurological Diseases and Stroke—a branch of the National Institutes of Health—established this award to identify the contributions of outstanding faculty mentors and the critical role they play in training and inspiring the next generation of scientists.

Sillitoe is the first Duncan NRI faculty member and second Baylor faculty to receive this award.

“Teaching is my passion, and I am honored to be selected for this esteemed award from a considerable pool of outstanding nominees. Most NIH faculty awards focus on supporting the core research interests of the faculty recipient, but this award is unique in that it is specifically created to enhance and advance the careers of our mentees who perform the bulk of experiments in the lab and advance our research programs,” Sillitoe explained.

This annual award is named in honor of a notable neurobiologist and former NINDS director, Dr. Story Landis.

Dr. Landis generously provided her time and energy to support endless scientific investigators as they navigated the professional landscape of biomedical research.

Additionally, being selected for this award has special meaning to Sillitoe since Dr. Landis also serves on the Duncan NRI’s advisory board and has provided valuable guidance to its leadership and faculty.

This is original content from NewsBreak’s Creator Program. Join today to publish and share your own content.

Comments / 0

Published by

Journalist. I believe in H-Town, Rockets, Lone Star Football and God.

Houston, TX

More from Marisol Gallagher

Comments / 0